TLR4 activation promotes podocyte injury and interstitial fibrosis in diabetic nephropathy

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Ma, Jin ^c   Chadban, Steven J ^a,c   Zhao, Cathy Y ^c   Chen, Xiaochen ^c   Kwan, Tony ^c   Panchapakesan, Usha ^b,c   Pollock, Carol A ^b,c   Wu, Huiling ^a,c  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD68 ANTIGEN; CHEMOKINE; CYTOKINE; DNA; FIBRONECTIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HEAT SHOCK PROTEIN 70; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIGAND; LYMPHOTOXIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; COLLAGEN; TLR4 PROTEIN, MOUSE;

ALBUMINURIA; ANIMAL EXPERIMENT; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DNA BINDING; EPITHELIUM CELL; FIBROSING ALVEOLITIS; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; KIDNEY HYPERTROPHY; MALE; MOUSE; MYOFIBROBLAST; NONHUMAN; PATHOPHYSIOLOGY; PODOCYTE; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; WILD TYPE; ANALYSIS OF VARIANCE; ANIMAL; BAGG ALBINO MOUSE; COMPLICATION; DIABETIC NEPHROPATHIES; EXPERIMENTAL DIABETES MELLITUS; FIBROSIS; FLUORESCENT ANTIBODY TECHNIQUE; GEL MOBILITY SHIFT ASSAY; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANALYSIS OF VARIANCE; ANIMALS; COLLAGEN; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FIBROSIS; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PODOCYTES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TOLL-LIKE RECEPTOR 4;

EID: 84901303677     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097985     Document Type: Article

References (42)

1. White SL, Cass A, Atkins RC, Chadban SJ (2005) Chronic kidney disease in the general population. Adv Chronic Kidney Dis 12: 5-13. (Pubitemid 40255598)
2. Mora C, Navarro JF (2006) Inflammation and diabetic nephropathy. Current diabetes reports 6: 463-468. (Pubitemid 44896406)
3. Tuttle KR (2005) Linking metabolism and immunology: diabetic nephropathy is an inflammatory disease. J Am Soc Nephrol 16: 1537-1538.
4. Anders HJ, Banas B, Schlondorff D (2004) Signaling danger: toll-like receptors and their potential roles in kidney disease. J Am Soc Nephrol 15: 854-867. (Pubitemid 38375304)
5. Vabulas RM, Ahmad-Nejad P, Ghose S, Kirschning CJ, Issels RD, et al. (2002) HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. The Journal of biological chemistry 277: 15107-15112. (Pubitemid 34952589)
6. Yu M, Wang H, Ding A, Golenbock DT, Latz E, et al. (2006) HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 26: 174-179. (Pubitemid 44162504)
7. Schaefer L, Babelova A, Kiss E, Hausser HJ, Baliova M, et al. (2005) The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J Clin Invest 115: 2223-2233. (Pubitemid 41134165)
8. Wu H, Chen G, Wyburn KR, Yin J, Bertolino P, et al. (2007) TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 117: 2847-2859. (Pubitemid 47529615)
9. Leemans JC, Stokman G, Claessen N, Rouschop KM, Teske GJ, et al. (2005) Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest 115: 2894-2903. (Pubitemid 41434417)
10. Zhang B, Ramesh G, Uematsu S, Akira S, Reeves WB (2008) TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity. J Am Soc Nephrol 19: 923-932.
11. Brown HJ, Sacks SH, Robson MG (2006) Toll-like receptor 2 agonists exacerbate accelerated nephrotoxic nephritis. J Am Soc Nephrol 17: 1931-1939. (Pubitemid 44036177)
12. Brown HJ, Lock HR, Wolfs TG, Buurman WA, Sacks SH, et al. (2007) Toll-like receptor 4 ligation on intrinsic renal cells contributes to the induction of antibody-mediated glomerulonephritis via CXCL1 and CXCL2. J Am Soc Nephrol 18: 1732-1739. (Pubitemid 46870310)
13. Devaraj S, Dasu MR, Rockwood J, Winter W, Griffen SC, et al. (2008) Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J Clin Endocrinol Metab 93: 578-583. (Pubitemid 351240834)
14. Dasu MR, Devaraj S, Park S, Jialal I (2010) Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes care 33: 861-868.
15. Lin M, Yiu WH, Wu HJ, Chan LY, Leung JC, et al. (2012) Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy. J Am Soc Nephrol 23: 86-102.
16. Devaraj S, Tobias P, Kasinath BS, Ramsamooj R, Afify A, et al. (2011) Knockout of toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathy. Arteriosclerosis, thrombosis, and vascular biology 31: 1796-1804.
17. Devaraj S, Tobias P, Jialal I (2011) Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes. Cytokine 55: 441-445.
18. Lin M, Yiu WH, Li RX, Wu HJ, Wong DW, et al. (2013) The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy. Kidney Int.
19. Kuwabara T, Mori K, Mukoyama M, Kasahara M, Yokoi H, et al. (2012) Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice. Diabetologia 55: 2256-2266.
20. Cha JJ, Hyun YY, Lee MH, Kim JE, Nam DH, et al. (2013) Renal protective effects of toll-like receptor 4 signaling blockade in type 2 diabetic mice. Endocrinology 154: 2144-2155.
21. Tsuboi N, Yoshikai Y, Matsuo S, Kikuchi T, Iwami K, et al. (2002) Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J Immunol 169: 2026-2033. (Pubitemid 34857667)
22. Banas MC, Banas B, Hudkins KL, Wietecha TA, Iyoda M, et al. (2008) TLR4 links podocytes with the innate immune system to mediate glomerular injury. J Am Soc Nephrol 19: 704-713.
23. Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, et al. (2007) TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 13: 1324-1332. (Pubitemid 350073596)
24. Weibel ER, Gomez DM (1962) A principle for counting tissue structures on random sections. J Appl Physiol 17: 343-348.
25. Melhem MF, Craven PA, Liachenko J, DeRubertis FR (2002) Alpha-lipoic acid attenuates hyperglycemia and prevents glomerular mesangial matrix expansion in diabetes. J Am Soc Nephrol 13: 108-116. (Pubitemid 34042017)
26. McWhinnie DL, Thompson JF, Taylor HM, Chapman JR, Bolton EM, et al. (1986) Morphometric analysis of cellular infiltration assessed by monoclonal antibody labeling in sequential human renal allograft biopsies. Transplantation 42: 352-358. (Pubitemid 16005759)
27. Lim AK, Ma FY, Nikolic-Paterson DJ, Thomas MC, Hurst LA, et al. (2009) Antibody blockade of c-fms suppresses the progression of inflammation and injury in early diabetic nephropathy in obese db/db mice. Diabetologia 52: 1669-1679.
28. Koop K, Eikmans M, Baelde HJ, Kawachi H, De Heer E, et al. (2003) Expression of podocyte-associated molecules in acquired human kidney diseases. Journal of the American Society of Nephrology : JASN 14: 2063-2071. (Pubitemid 36909914)
29. Venkatareddy M, Wang S, Yang Y, Patel S, Wickman L, et al. (2013) Estimating Podocyte Number and Density Using a Single Histologic Section. J Am Soc Nephrol.
30. Takemoto M, Asker N, Gerhardt H, Lundkvist A, Johansson BR, et al. (2002) A new method for large scale isolation of kidney glomeruli from mice. The American journal of pathology 161: 799-805. (Pubitemid 34988366)
31. Wu H, Ma J, Wang P, Corpuz TM, Panchapakesan U, et al. (2010) HMGB1 contributes to kidney ischemia reperfusion injury. Journal of the American Society of Nephrology : JASN 21: 1878-1890.
32. Mauer M, Drummond K (2002) The early natural history of nephropathy in type 1 diabetes: I. Study design and baseline characteristics of the study participants. Diabetes 51: 1572-1579. (Pubitemid 34826627)
33. Kerjaschki D (2001) Caught flat-footed: podocyte damage and the molecular bases of focal glomerulosclerosis. The Journal of clinical investigation 108: 1583-1587.
34. Meyer TW, Bennett PH, Nelson RG (1999) Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria. Diabetologia 42: 1341-1344. (Pubitemid 29500971)
35. Qian Y, Feldman E, Pennathur S, Kretzler M, Brosius FC, 3rd (2008) From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy. Diabetes 57: 1439-1445.
36. Timmers L, Sluijter JP, van Keulen JK, Hoefer IE, Nederhoff MG, et al. (2008) Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction. Circ Res 102: 257-264. (Pubitemid 351674064)
37. Pulskens WP, Rampanelli E, Teske GJ, Butter LM, Claessen N, et al. (2010) TLR4 promotes fibrosis but attenuates tubular damage in progressive renal injury. J Am Soc Nephrol 21: 1299-1308.
38. Border WA, Noble NA (1994) Transforming growth factor beta in tissue fibrosis. N Engl J Med 331: 1286-1292. (Pubitemid 24333194)
39. Vernon MA, Mylonas KJ, Hughes J (2010) Macrophages and renal fibrosis. Semin Nephrol 30: 302-317.
40. Chen HY, Huang XR, Wang W, Li JH, Heuchel RL, et al. (2011) The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential. Diabetes 60: 590-601.
41. Tesch GH (2007) Role of macrophages in complications of type 2 diabetes. Clin Exp Pharmacol Physiol 34: 1016-1019.
42. Campbell MT, Hile KL, Zhang H, Asanuma H, Vanderbrink BA, et al. (2011) Toll-like receptor 4: a novel signaling pathway during renal fibrogenesis. J Surg Res 168: e61-69.